Abiopharma

🔍 Pritzker Jennifer N. (Executive)

Company: ORTHOPEDIATRICS CORP (KIDS)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Sold 326,700 shares of Common Stock at $23.04 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 6,536,764.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 10,131 shares of Common Stock at $23.1 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 6,526,633.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | shares_owned_after: 10,900.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 1,300.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 1,300.00 | Footnotes: F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 707.00 | Footnotes: F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 500.00 | Footnotes: F8

Footnotes:

• F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: These securities are held directly by Squadron Capital LLC ("Squadron"), a manager-managed limited liability company. As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F5: These shares are held by the Tawani Foundation. As the sole member of the Tawani Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.
• F6: These shares are held by the Pritzker Military Foundation. As the sole member of the Pritzker Military Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.
• F7: These shares are held by the reporting person's spouse, and the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.
• F8: These shares are held by the Pritzker Military Museum and Library ("PMML"). As the sole member of PMML, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.